Drewinko B, Moskwa P, Lotzovà E, Trujillo J M
Invasion Metastasis. 1986;6(2):69-82.
Six established human colon carcinoma cell lines with distinct degrees of cell differentiation were inoculated into infant (less than 4 weeks) and adult (greater than 8 weeks) nude rats. The most differentiated tumor cells (group I) had nearly a 100% rate of tumor takes whether inoculated subcutaneously, intraperitoneally, or intracerebrally into adult rats; subcutaneous growth continued unabated for a 120-day observation period. Cells with intermediate differentiation (group II) had nearly an 80% incidence in tumor takes when injected subcutaneously and 14-60% when injected intraperitoneally. Subcutaneous growth continued only for about 30 days, after which time growth declined, and tumors regressed completely. Intracerebral inoculations of group II cells resulted in 64-83% tumor takes. Subcutaneous injections of cells from groups I and II into 5- to 10-day-old rats resulted in 100% tumor takes; tumors induced by group II did not regress, and after about 60 days reached volumes comparable to those originated by cells from group I. No tumors developed when cells from group III (undifferentiated) were injected either subcutaneously or intraperitoneally (and even intravenously) into adult rats. Only when the intracerebral route was employed was there a 60-71% incidence of tumor takes. Also, for one of the cell lines in this group, subcutaneous injection into infant rats resulted in 100% tumor takes. NK cell activity of infant rats against all of the colon cells (measured by the 51Cr release assay) was negligible; in adult rats, the activity varied according to the cell type, being usually highest against the less differentiated tumors. Our data on the incidence of tumor takes, and on the dynamics of tumor growth and decline suggest that successful heterotransplantation of human colon carcinoma cells into nude rats depends on the activity of host NK cells. In turn, this activity seems related to the degree of cell differentiation and the growth kinetics of the xenografted tumor cells. These observations highlight important differences in biological characteristics of human colon carcinoma with important implications for their intrinsic ability to grow and metastasize, and, possibly, their response to biological response modifiers.
将六种具有不同细胞分化程度的人结肠癌细胞系接种到幼年(小于4周)和成年(大于8周)裸鼠体内。分化程度最高的肿瘤细胞(I组)无论皮下、腹腔内还是脑内接种到成年大鼠体内,肿瘤形成率几乎都达到100%;在120天的观察期内,皮下生长持续且无减缓。中等分化的细胞(II组)皮下注射时肿瘤形成率接近80%,腹腔内注射时为14%-60%。皮下生长仅持续约30天,之后生长减缓,肿瘤完全消退。II组细胞脑内接种的肿瘤形成率为64%-83%。将I组和II组细胞皮下注射到5至10日龄大鼠体内,肿瘤形成率为100%;II组诱导的肿瘤未消退,约60天后达到与I组细胞起源的肿瘤相当的体积。当将III组(未分化)细胞皮下、腹腔内(甚至静脉内)注射到成年大鼠体内时,未形成肿瘤。只有采用脑内接种途径时,肿瘤形成率为60%-71%。此外,对于该组中的一种细胞系,皮下注射到幼年大鼠体内的肿瘤形成率为100%。幼年大鼠对所有结肠癌细胞的NK细胞活性(通过51Cr释放试验测量)可忽略不计;在成年大鼠中,活性因细胞类型而异,通常对分化程度较低的肿瘤活性最高。我们关于肿瘤形成率、肿瘤生长和消退动态的数据表明,人结肠癌细胞成功异种移植到裸鼠体内取决于宿主NK细胞的活性。反过来,这种活性似乎与细胞分化程度和异种移植肿瘤细胞的生长动力学有关。这些观察结果突出了人结肠癌生物学特性的重要差异,对其生长和转移的内在能力以及可能对生物反应调节剂的反应具有重要意义。